To discuss the integration of AI technologies in eyecare and their impact on diagnostics, imaging, workflow, and patient management, as presented by Dr. Jessilin Quint.
Approach:
Key Findings:
AI can autonomously diagnose conditions like diabetic retinopathy, as demonstrated by FDA-cleared systems.
AI tools can optimize patient scheduling and engagement, as discussed by Dr. Quint.
AI is being developed for various diagnostic applications, including glaucoma and keratoconus detection, as mentioned by Dr. Quint.
Challenges include data privacy, algorithm bias, and the need for diverse datasets, as highlighted by Dr. Quint.
Interpretation:
Dr. Quint emphasized that AI should augment, not replace, clinical judgment, and maintaining patient trust and empathy is essential.
Limitations:
Technical limitations and data privacy concerns, as noted by Dr. Quint.
Need for high-quality annotated datasets, according to Dr. Quint.
Clinical trust and acceptance issues regarding AI recommendations, as discussed by Dr. Quint.
Conclusion:
Dr. Quint stated that AI will reshape clinical eye care, emphasizing the importance of ethical integration and clinician oversight.
Justin Schweitzer, OD, FAAO, and Jessica Steen, OD, FAAO, describe emerging technologies, treatment strategies, and clinical considerations that can help eyecare professionals (ECPs) identify glaucoma earlier and better manage progression.